<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xmlns:fr="http://www.crossref.org/fundref.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1689398166</doi_batch_id>
    <timestamp>20230715051606000</timestamp>
    <depositor>
      <depositor_name>Editor</depositor_name>
      <email_address>editor.jddt@gmail.com</email_address>
    </depositor>
    <registrant>Universal Journal of Pharmaceutical Research</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Universal Journal of Pharmaceutical Research</full_title>
        <abbrev_title>Univ J Pharm Res</abbrev_title>
        <issn media_type="electronic">2456-8058</issn>
        <issn media_type="print">2831-5235</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>07</month>
          <day>15</day>
          <year>2023</year>
        </publication_date>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" publication_type="full_text" metadata_distribution_opts="any">
        <titles>
          <title>EVALUATION OF METRONIDAZOLE TABLETS FORMULATED WITH DIFFERENT DISINTEGRANTS USING MOISTURE ACTIVATED DRY GRANULATION </title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first" language="en">
            <given_name>Ezegbe Chekwube</given_name>
            <surname>Andrew</surname>
            <ORCID>https://orcid.org/0000-0003-2831-1006</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Ezegbe Amarachi</given_name>
            <surname>Grace</surname>
            <ORCID>https://orcid.org/0000-0002-5026-0690</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Chime Amarachi</given_name>
            <surname>Salome</surname>
            <ORCID>https://orcid.org/0000-0001-8082-121X</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Ugwu Calister</given_name>
            <surname>Elochukwu</surname>
            <ORCID>https://orcid.org/0000-0002-6656-7902</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Boniface Christian</given_name>
            <surname>Izuchukwu</surname>
            <ORCID>https://orcid.org/0000-0002-4858-9155</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Ugwuoke Kenneth</given_name>
            <surname>Ejiofor</surname>
            <ORCID>https://orcid.org/0000-0003-3317-3023</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Chukwuemeka Chizoba</given_name>
            <surname>Lorrita</surname>
            <ORCID>https://orcid.org/0000-0003-2402-5088</ORCID>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Onunkwo</given_name>
            <surname>Godswill</surname>
            <ORCID>https://orcid.org/0000-0003-3559-7858</ORCID>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1">
          <jats:p>Introduction:  Metronidazole is a synthetic oral nitroimidazole antibiotic used in the treatment of infections caused by anaerobic bacteria and protozoa. It also has amebicidal and antiprotozoal properties.
Aim: The purpose of the study was to formulate and evaluate metronidazole tablets formulated with polymers (PVP and PEG) and maize starch as disintegrant using moisture activated dry granulation (MADG).
Method: Twenty-four (24) batches of metronidazole granules and tablets were prepared by moisture activated dry granulation.  Metronidazole (200 mg), lactose and gelatin (1, 2, 4, and 8 %) were mixed, followed by continuous mixing. Prior to compression, micro-crystalline cellulose, disintegrants and magnesium stearate were added. The dried granules were passed via 1.0 mm sieve after which they were labelled and stored in an air tight container. All other batches were also similarly prepared.
Result: The result showed that the mean weight of the tablets ranged from 0.33±0.01 to 0.35±0.04 g. Tablet hardness ranged from 5.00±0.85 to 6.36±1.43. The results showed that batch 11 tablets had higher crushing strength than batch 24 with a significant difference. Table 2 shows the hardness test results and clearly indicates that the results of all the samples significantly differ from each other (p&lt;0.05). The tablet friability test ranged from 0.21±0.17 for batch 24 and 0.60±0.16 for batch 11.  The formulated tablets showed average disintegration time ranges from 0.52±0.01 to 14.03±0.03. According to USP, the disintegration time must be in the range of 15 min for uncoated tablets, and 30 mins for film coated tablets.
Conclusion: The study established that polyethylene glycol and polyvinyl pyrrolidone polymers had better dissolution profile than maize starch which has the best disintegration properties.
                         
Peer Review History: 
Received: 4 March 2023; Revised: 26 April; Accepted: 20 June 2023, Available online: 15 July 2023
Academic Editor: Dr. Jennifer Audu-Peter, University of Jos, Nigeria, drambia44@gmail.com
Received file:                             Reviewer's Comments:
Average Peer review marks at initial stage: 5.0/10
Average Peer review marks at publication stage: 7.0/10
Reviewers:
Dr. Julie Ann S. Ng, Blk 18 Lot 6 Grandville 3 Subdivision Mansilingan, Bacolod City, Philippines.  julieann_ng@yahoo.com
Dr. Essam Mohamed Eissa, Beni-Suef – 32 Tahrir St, Egypt, dressamceutics@yahoo.com</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>07</month>
          <day>15</day>
          <year>2023</year>
        </publication_date>
        <fr:program name="fundref"/>
        <ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators">
          <ai:license_ref>http://creativecommons.org/licenses/by-nc/4.0</ai:license_ref>
        </ai:program>
        <doi_data>
          <doi>10.22270/ujpr.v8i3.951</doi>
          <resource>https://ujpr.org/index.php/journal/article/view/951</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>https://ujpr.org/index.php/journal/article/download/951/1418</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://ujpr.org/index.php/journal/article/download/951/1418</resource>
            </item>
            <item>
              <resource mime_type="text/xml">https://ujpr.org/index.php/journal/article/download/951/1425</resource>
            </item>
            <item>
              <resource mime_type="text/html">https://ujpr.org/index.php/journal/article/download/951/1437</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>
